Bringing the fundamentals into focus…
Back to Acadia Pharmaceuticals Inc.
How Acadia Pharmaceuticals Inc. stacks up
ACAD · against 270 other Healthcare companies of similar size
Growth
80/ 100
Above the middle of the pack.
Ranked #71 of 271 · scores higher than 74% of peers
Bars: peers in each 10-point band of the growth score38 peers with a growth score of 80–89, including ACAD · Click a bar to see the companies
Why growth scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over the last year: stronger than 65% of peers. Revenue growth: 11.8% vs peer median 6.1%
- faster growth in earnings per share: stronger than 81% of peers. Earnings per share growth: 68.0% vs peer median 9.8%
- faster revenue growth over three years: stronger than 86% of peers. 3-year revenue growth: 27.4% vs peer median 5.8%
Metric by metric
Position: dot = ACAD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ACAD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 271 reported | 11.8% | 7.8% | 60% | 33% | |
| Earnings per share growthHigher is better · 173 reported | 68.0% | 10.1% | 78% | 33% | |
| 3-year revenue growthHigher is better · 264 reported | 27.4% | 8.5% | 86% | 33% |
Ranking by growth score
Top 5 and the companies ranked around ACAD| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 66 | 15.6B CNY (≈$2.2B) | 81 | 79 | |
| 66 | 249.2B INR (≈$3.0B) | 81 | 73 | |
| 66 | 379.9B INR (≈$4.6B) | 81 | 55 | |
| 66 | 2.7B USD | 81 | 56 | |
| 71 | 3.5B USD | 80 | 75 | |
| 72 | 15.8B HKD (≈$2.0B) | 79 | 61 | |
| 72 | 5.8B USD | 79 | 64 | |
| 72 | 5.2B CHF (≈$5.9B) | 79 | 69 | |
| 75 | 15.3B CNY (≈$2.1B) | 77 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score